Health
Revolutionary CRISPR-based Genome Editing System Destroys Cancer Cells ‘Permanently’ in Lab – Good News Network
A Tel Aviv University team shows their CRISPR genome editing system can improve survival rates by 80% in mice with metastatic ovarian cancer.
Researchers at Tel Aviv University have demonstrated that the CRISPR genome editing system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer.
In a paper published this week, the researchers demonstrated a novel lipid nanoparticle-based delivery system that specifically targets cancer cellsand co-author Prof. Dan Peer said it’s the first study in the world to prove that the CRISPR/Cas9 can be used to treat cancer effectively in a living animal.
…
-
Noosa News24 hours agoThe best new books released in August, from Toni Jordan, Rhett Davis and more
-
Business23 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares
-
Business21 hours agoHow to build a million-dollar ASX share portfolio in 25 years
-
General21 hours agoLabor’s socialist bedroom tax | The Spectator Australia